CollPlant Biotechnologies Ltd.
CLGN
$0.42
$0.013.38%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -63.41% | -28.11% | -45.15% | -90.70% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -63.41% | -28.11% | -45.15% | -90.70% | |
| Cost of Revenue | -29.41% | -65.30% | -64.81% | -2.16% | |
| Gross Profit | -22.22% | 97.56% | 77.22% | -14.04% | |
| SG&A Expenses | -21.54% | -18.57% | -10.67% | -15.97% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -22.43% | -27.88% | -22.90% | -2.13% | |
| Operating Income | 20.73% | 27.87% | 21.59% | 1.30% | |
| Income Before Tax | 17.30% | 20.50% | 17.30% | 1.17% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | 17.30% | 20.50% | 17.30% | 1.17% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 17.30% | 20.50% | 17.30% | 1.17% | |
| EBIT | 20.73% | 27.87% | 21.59% | 1.30% | |
| EBITDA | 21.38% | 28.85% | 21.99% | 0.99% | |
| EPS Basic | 25.93% | 23.07% | 17.29% | 1.25% | |
| Normalized Basic EPS | 25.90% | 23.07% | 17.31% | -- | |
| EPS Diluted | 25.93% | 23.07% | 17.29% | 1.25% | |
| Normalized Diluted EPS | 25.90% | 23.07% | 17.31% | -- | |
| Average Basic Shares Outstanding | 11.62% | 3.37% | 0.01% | 0.10% | |
| Average Diluted Shares Outstanding | 11.62% | 3.37% | 0.01% | 0.10% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |